Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Status:
Completed
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, open-label, multicenter study in approximately 52 adults with primary
(de novo) GB that has recurred or progressed (first or second recurrence, including this
recurrence) after treatment(s) including surgery and radiotherapy with or without
chemotherapy and following discontinuation of any previous standard or investigational lines
of therapy.